Drug General Information
Drug ID	D09PNQ
Former ID	DNC008424
Drug Name	2,3-dihydroxypropanal
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[529225]
Structure		Download 2D MOL 3D MOL
Formula	C3H6O3
Canonical SMILES	C(C(C=O)O)O
InChI	1S/C3H6O3/c4-1-3(6)2-5/h1,3,5-6H,2H2
InChIKey	MNQZXJOMYWMBOU-UHFFFAOYSA-N
PubChem Compound ID	751
Target and Pathway
Target(s)	Aldose reductase	Target Info	Inhibitor	[529225]
BioCyc Pathway	Methylglyoxal degradation III
	Acetone degradation I (to methylglyoxal)
KEGG Pathway	Pentose and glucuronate interconversions
	Fructose and mannose metabolism
	Galactose metabolism
	Glycerolipid metabolism
	Metabolic pathways
NetPath Pathway	IL1 Signaling Pathway
	TGF_beta_Receptor Signaling Pathway
PathWhiz Pathway	Fructose and Mannose Degradation
	Pyruvate Metabolism
	Pterine Biosynthesis
	Glycerolipid Metabolism
	Galactose Metabolism
WikiPathways	Metapathway biotransformation
	Polyol Pathway
	Metabolism of steroid hormones and vitamin D
References
Ref 529225	Proc Natl Acad Sci U S A. 2007 Dec 26;104(52):20764-9. Epub 2007 Dec 17.Structural basis for the high all-trans-retinaldehyde reductase activity of the tumor marker AKR1B10.
Ref 529225	Proc Natl Acad Sci U S A. 2007 Dec 26;104(52):20764-9. Epub 2007 Dec 17.Structural basis for the high all-trans-retinaldehyde reductase activity of the tumor marker AKR1B10.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.